Skip to content

Thin Coatings For Better Hips

Facebook
Twitter
LinkedIn

By the year 2030, due to the rise in age-expectancy and accompanying increase in frequency in bone-weakening conditions, total hip replacement surgeries will increase by 174%. One of the most important facets of implant surgery is biocompatibility. Durable implants that are biocompatible with human tissue are needed to prevent rejection and failure. And with this logarithmic expected rise, the need for longer lasting implants will be needed more than ever before.

Currently, metallic biomedical implants are the most common type. These, however, have a limited durability, often requiring surgery to be replaced after a decade. The combined action of wear and corrosion (termed tribocorrosion), brought about by friction during joint movements and the body’s aggressive environment, causes implant failure. A material called biomedical grade 316 LVM stainless steel is commonly used in hip-joint implants. It naturally forms a thin oxide film on its surface that protects the material from the body’s hostile environment. The problem with stainless steels is that despite this natural coat, tribocorrosion processes at the joints still form debris leading to problems for the patient and implant failure. Such failure can cause severe pain and expense when the hip implant needs to be replaced.

Antonino Mazzonello (supervised by Dr Ing. Bertram Mallia and Dr Ing. Joseph Buhagiar), is investigating a new type of coating on hip implants. He is analysing the corrosion-wear performance of a dual-layer coating made up of a Chrome-Nitride (Cr-N) layer followed by a Cobalt-Chrome-Molybdenum-Carbide (Co-Cr-Mo-C) layer deposited on top of low-temperature carburised stainless steel (the coatings are made by Prof. Peter Dearnely [Boride Services Ltd.]. This treatment is owned and carried out by Bodycote Plc. The top layer reduces friction while the bottom layer toughens the coating, reducing its removal. When the dual-layered stainless steel is compared to the untreated steel, the treated material is more resistant to wear and corrosion.

This new dual-coated material promises to be an ideal candidate for hip joint implants. Apart from being harder and more resistant, its low friction means that less effort would be required to move the joint. The encouraging results mean that in the near future this technology could be implemented in clinics. Mallia points out that ‘such multi-layered coatings may offer a giant step in increased durability for a relatively small additional expense.’


 This research is being performed as part of a Master’s degree in Mechanical Engineering, which Antonino Mazzonello is reading at the Faculty of Engineering, University of Malta. The research is supported by an Endeavour Scholarship. This scholarship is part-financed by the European Union; European Social Fund under Operational Programme II (ESF) 2014-2020, “Investigating in human capital to create more opportunities and promote the wellbeing of society”.
by Antonino Mazzonello

Author

More to Explore

These Insoles Are Made for Monitoring: A Step Towards Preventive Healthcare 

What if healthcare could learn more about our health between appointments? Wearable technology is opening up new possibilities for continuous monitoring, and researchers at UM’s Centre for Biomedical Cybernetics and Department of Podiatry, in collaboration with Tarsos, are making significant contributions in this area. THINK went to learn more about a research project investigating how smart insoles could improve foot health monitoring for people with diabetes.

The Chosen One? Adoption Beyond the ‘Happy Ending’

You look at your reflection in the mirror. Your face tells a story of the generations that came before you. A familiar smile, or a shared eye colour, a resemblance that has probably been pointed out more than once. For most, such observations are brushed off with a smile and quickly forgotten. But what if your reflection raised more questions than answers?

Molecular Mail: Tiny Parcels for Tracking Tumours

Tumours are not discreet. As cancer cells grow and change, they release microscopic particles into their environment. Some of these particles enter the bloodstream. They are small, abundant, and, as researchers are beginning to realise, potentially informative. A Maltese research project is testing whether extracellular vesicles can provide a less invasive source of cancer information.

Comments are closed for this article!